Compare NOTV & BNKK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NOTV | BNKK |
|---|---|---|
| Founded | 1974 | 2018 |
| Country | United States | United States |
| Employees | N/A | 10 |
| Industry | Biotechnology: Pharmaceutical Preparations | Package Goods/Cosmetics |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.8M | 11.9M |
| IPO Year | 1997 | N/A |
| Metric | NOTV | BNKK |
|---|---|---|
| Price | $0.08 | $1.35 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $1.50 | N/A |
| AVG Volume (30 Days) | ★ 59.5M | 423.5K |
| Earning Date | 05-11-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 49.64 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $547,656,000.00 | N/A |
| Revenue This Year | $5.28 | N/A |
| Revenue Next Year | $5.42 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 511.19 | N/A |
| 52 Week Low | $0.08 | $0.11 |
| 52 Week High | $2.44 | $7.19 |
| Indicator | NOTV | BNKK |
|---|---|---|
| Relative Strength Index (RSI) | 31.45 | 28.58 |
| Support Level | N/A | $0.12 |
| Resistance Level | $0.33 | $2.90 |
| Average True Range (ATR) | 0.04 | 0.18 |
| MACD | -0.02 | -0.02 |
| Stochastic Oscillator | 0.70 | 11.75 |
Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.
Bonk Inc provides over-the-counter products and consumer products in the United States. The company offers Safety Shot Beverage, an over-the-counter drink that lowers blood alcohol content. It sells its products through direct customers, distributors, retailers, and e-commerce websites. The company generates revenue through various channels, its primary sales include nostingz suncare products which are sold through e-commerce platforms, licensing revenues from Photocil and sales of the Safety Shot Beverage. The company has two reportable segments: the dietary and energy beverage business and digital assets, consisting of investing for growth in the appreciation of the asset. It derives the majority of the revenue from the dietary and energy beverage segment.